Search Results (1)

The global burden of cancer is increasing rapidly, and nanomedicine offers promising prospects for enhancing the life expectancy of cancer patients. Janus nanoparticles (JNPs) have garnered considerable attention due to their asymmetric geometry, enabling multifunctionality in drug delivery and theranostics. However, achieving precise control over the self-assembly of JNPs in solution at the nanoscale level poses significant challenges. Herein, a low-temperature reversed-phase microemulsion system was used to obtain homogenous Mn₃O₄-Ag₂S JNPs, which showed significant potential in cancer theranostics. Structural characterization revealed that the Ag₂S (5–10 nm) part was uniformly deposited on a specific surface of Mn₃O₄ to form a Mn₃O₄-Ag₂S Janus morphology. Compared to the single-component Mn₃O₄ and Ag₂S particles, the fabricated Mn₃O₄-Ag₂S JNPs exhibited satisfactory biocompatibility and therapeutic performance. Novel diagnostic and therapeutic nanoplatforms can be guided using the magnetic component in JNPs, which is revealed as an excellent T₁ contrast enhancement agent in magnetic resonance imaging (MRI) with multiple functions, such as photo-induced regulation of the tumor microenvironment via producing reactive oxygen species and second near-infrared region (NIR-II) photothermal excitation for in vitro tumor-killing effects. The prime antibacterial and promising theranostics results demonstrate the extensive potential of the designed photo-responsive Mn₃O₄-Ag₂S JNPs for biomedical applications. Full article